What US 21 CFR Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals requires
US 21 CFR Part 211 prescribes the cGMP requirements for finished pharmaceuticals manufactured, processed, packed, or held in the US…
This is a preview. The full record adds the complete summary, 8 workflow steps, 16 schema fields and 5 primary citations. Start a free trial or see pricing.
Pillar: Pharmaceuticals & Life Sciences · Authority: US FDA · Version: 1.0.0 · Last updated:
Primary source: https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211
SHA-256 integrity: 326bf80c890d96f424d015fd638767b3efd1cc04330dfeccf705ff16c8d2068b
Primary Citations — 5 traced to source
- US 21 CFR Current Good Manufacturing Practice for Finished Pharmaceuticals
- US 21 CFR § 211.22 Responsibilities of quality control unit
+ 3 more citations (full bibliography, deterministic workflow, actionable schema and crosswalks) included in the vault unlock — $0.01 via Skyfire / L402 / Direct Base USDC.
Access
- Discovery (free): /api/v1/nodes/us-21-cfr-part-211-cgmp-finished-pharmaceuticals.json — 6-field metadata
- Vault (full node): /api/v1/vault/nodes/us-21-cfr-part-211-cgmp-finished-pharmaceuticals.json — full 13-key payload, $0.01 USDC (L402/Skyfire/Direct Base)
- Canonical URL: https://bidda.com/intelligence/us-21-cfr-part-211-cgmp-finished-pharmaceuticals
- Back to registry: Browse all 10,102 compliance nodes